Statin Disappoints for Treatment-Resistant Depression
Adding simvastatin to standard therapy offers no benefit over placebo for treatment-resistant depression, a new randomized clinical trial shows.
Stay updated with breaking news from Ipid Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Adding simvastatin to standard therapy offers no benefit over placebo for treatment-resistant depression, a new randomized clinical trial shows.
Tyrosine kinase inhibitors markedly improve patients' chances of survival but also cause a rise in blood pressure that must be treated quickly.
A large meta-analysis raises more questions about the benefit of low-dose aspirin in people who don't have atherosclerotic cardiovascular disease.
The first-of-its-kind document is an "indispensable tool" for promoting and standardizing best practices, say the authors.
A new study says playing 18 holes (sans golf cart) is just as good, and maybe better, as brisk walking or Nordic walking for cardiovascular health in older adults.